Results 231 to 240 of about 1,209,228 (250)

Discovery and Development of the Oral Complement Factor D Inhibitor Danicopan (ACH-4471)

Current Medicinal Chemistry, 2020
Steven D Podos
exaly  

An inhibitor of complement C5 provides structural insights into activation

Proceedings of the National Academy of Sciences of the United States of America, 2020
Martin Parnov Reichhardt, Justin Deme, Susan Lea   +2 more
exaly  

Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activation

Frontiers in Immunology, 2023
Alonso Ricardo, Petra W Duda
exaly  

New Treatment Options for Atypical Hemolytic Uremic Syndrome with the Complement Inhibitor Eculizumab

Seminars in Thrombosis and Hemostasis, 2010
Thérèse Jungraithmayr
exaly  

New insight into the effects of heparinoids on complement inhibition by C1-inhibitor

Clinical and Experimental Immunology, 2016
Jeffrey Damman, Felix Poppelaars
exaly  

Kinetics of reaction of human C-inhibitor with the human complement system proteases Cr and Cs

Biochimica Et Biophysica Acta - Biomembranes, 1980
Robert Sim, G J Arlaud, Maurice G Colomb   +2 more
exaly  

Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement

Molecular Immunology, 2007
Hilde Fure, Tom Mollnes, Erik Waage Nielsen   +2 more
exaly  

Hydrodynamic data show that C1̄ inhibitor of complement forms compact complexes with C1̄r and C1̄s

FEBS Letters, 1990
Stephen Perkins
exaly  

Primate terminal complement inhibitor homologues of human CD59

Immunogenetics, 1995
Stephen P Squinto, S A Rollins, William L Fodor   +2 more
exaly  

Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria

Blood, 2007
Peter Hillmen, Robert Brodsky, Jeff Szer   +2 more
exaly